NCT04461210

Brief Summary

Annotated pain maps will be created showing region and size of areas sensitive to mechanical stimulus in both women affected by vulvar pain and unaffected control patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 8, 2020

Completed
1.6 years until next milestone

Study Start

First participant enrolled

February 28, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

July 8, 2025

Completed
Last Updated

July 8, 2025

Status Verified

July 1, 2025

Enrollment Period

1.9 years

First QC Date

July 2, 2020

Results QC Date

April 21, 2025

Last Update Submit

July 5, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Annotated Pain Mapping

    Develop annotated pain maps showing region and size of area sensitive to mechanical stimulus. A cotton swab is used to lightly touch the vulva in 18 different locations and participant's assessment of pain on a scale of 0-10 is recorded.

    Duration of study visit, approximately 1 hour

  • Quantitative Pain Description of the Vulva With Touch.

    The vulva is lightly touched with a cotton swab at 18 locations of the vulva. Participants rate pain at each location on a scale of 0-10, with 0 being no pain and 10 being worst. Only the pain scores from the 7 points of the inner vulva are presented here, since that is the primary site of pain in women with provoked vulvodynia.

    Immediate

Secondary Outcomes (2)

  • Thermographic Imaging of the Vulva.

    Duration of study visit, approximately 1 hour

  • Thermographic Imaging of the Vulva

    Duration of study visit, about 1 hour

Study Arms (2)

Vulvodynia

Women with localized, provoked vulvodynia

Diagnostic Test: Thermographic Imaging and Mechanical Pain Assessment

Health Controls

Women without vulvar pain or other vulvar disorders.

Diagnostic Test: Thermographic Imaging and Mechanical Pain Assessment

Interventions

Assessment of pain sensitivity with mechanical stimulus (cotton swab) and thermographic imaging with infrared camera

Health ControlsVulvodynia

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsVulvodynia is a sex-specific disorder. Only women will be enrolled.
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Women with localized, provoked vulvodynia and healthy controls without vulvar pain or other vulvar disorders.

You may qualify if:

  • women meeting criteria for vulvodynia women seeking care for routine gynecologic exam

You may not qualify if:

  • women less than 18 years of age current pregnancy women with vulvar or vaginal disorder other than pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UBMD Obstetrics and Gynecology

Buffalo, New York, 14203, United States

Location

MeSH Terms

Conditions

Vulvodynia

Condition Hierarchy (Ancestors)

Vulvar DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Results Point of Contact

Title
Director of the Clinical and Translational Science Institute
Organization
University at Buffalo

Study Officials

  • Vanessa M Barnabei, MD, PhD

    University at Buffalo

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 2, 2020

First Posted

July 8, 2020

Study Start

February 28, 2022

Primary Completion

January 6, 2024

Study Completion

January 6, 2024

Last Updated

July 8, 2025

Results First Posted

July 8, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations